HomeCompareBPMC vs MCD

BPMC vs MCD: Dividend Comparison 2026

BPMC yields 1.54% · MCD yields 2.35%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MCD wins by $56.6K in total portfolio value· pulled ahead in Year 2
10 years
BPMC
BPMC
● Live price
1.54%
Share price
$129.46
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.9K
Annual income
$170.75
Full BPMC calculator →
MCD
McDonald's Corporation
● Live price
2.35%
Share price
$308.53
Annual div
$7.26
5Y div CAGR
42.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$78.5K
Annual income
$26,227.70
Full MCD calculator →

Portfolio growth — BPMC vs MCD

📍 MCD pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBPMCMCD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BPMC + MCD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BPMC pays
MCD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BPMC
Annual income on $10K today (after 15% tax)
$131.31/yr
After 10yr DRIP, annual income (after tax)
$145.14/yr
MCD
Annual income on $10K today (after 15% tax)
$200.01/yr
After 10yr DRIP, annual income (after tax)
$22,293.55/yr
At 15% tax rate, MCD beats the other by $22,148.41/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BPMC + MCD for your $10,000?

BPMC: 50%MCD: 50%
100% MCD50/50100% BPMC
Portfolio after 10yr
$50.2K
Annual income
$13,199.22/yr
Blended yield
26.28%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MCD right now

BPMC
Analyst Ratings
1
Strong
17
Buy
15
Hold
1
Sell
Consensus: Buy
Price Target
$113.07
-12.7% upside vs current
Range: $41.00 — $155.00
Altman Z
3.7
Piotroski
4/9
MCD
Analyst Ratings
37
Buy
23
Hold
1
Sell
Consensus: Buy
Price Target
$351.76
+14.0% upside vs current
Range: $320.00 — $385.00
Altman Z
4.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BPMC buys
0
MCD buys
0
No recent congressional trades found for BPMC or MCD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBPMCMCD
Forward yield1.54%2.35%
Annual dividend / share$2.00$7.26
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%42.3%
Portfolio after 10y$21.9K$78.5K
Annual income after 10y$170.75$26,227.70
Total dividends collected$1.6K$58.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary
Analyst consensusBuyBuy
Analyst price target$113.07$351.76

Year-by-year: BPMC vs MCD ($10,000, DRIP)

YearBPMC PortfolioBPMC Income/yrMCD PortfolioMCD Income/yrGap
1$10,854$154.49$10,815$334.85+$39.00BPMC
2← crossover$11,771$156.72$11,826$491.71$55.00MCD
3$12,754$158.83$13,123$730.06$369.00MCD
4$13,807$160.84$14,853$1,100.07$1.0KMCD
5$14,937$162.73$17,257$1,690.61$2.3KMCD
6$16,147$164.52$20,752$2,667.01$4.6KMCD
7$17,443$166.22$26,103$4,354.83$8.7KMCD
8$18,832$167.82$34,794$7,437.78$16.0KMCD
9$20,320$169.33$49,926$13,461.60$29.6KMCD
10$21,913$170.75$78,550$26,227.70$56.6KMCD

BPMC vs MCD: Complete Analysis 2026

BPMCStock

Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of non-advanced SM and other mast cell disorders; and Fisogatinib, an orally available and potent inhibitor for the treatment of hepatocellular carcinoma. It is also developing GAVRETO for the treatment of RET fusion-positive non-small cell lung cancer, altered solid tumors, medullary thyroid carcinoma, and other solid tumors; BLU-701 and BLU-945 for the treatment of epidermal growth factor receptor driven non-small-cell lung carcinoma (NSCLC); and BLU-451 to treat NSCLC in patients with epidermal growth factor receptor gene (EGFR) exon 20 insertion mutations. In addition, the company is developing BLU-782, for the treatment of fibrodysplasia ossificans progressive; BLU- 222 to treat patients with cyclin E aberrant cancers; and BLU-852 for the treatment of advanced cancers. It has collaboration and license agreements with Clementia Pharmaceuticals, Inc.; Proteovant Therapeutics; CStone Pharmaceuticals; Genentech, Inc.; F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; and Zai Lab (Shanghai) Co., Ltd. The company was formerly known as Hoyle Pharmaceuticals, Inc. and changed its name to Blueprint Medicines Corporation in June 2011. Blueprint Medicines Corporation was incorporated in 2008 and is headquartered in Cambridge, Massachusetts.

Full BPMC Calculator →

MCDConsumer Discretionary

McDonald's Corporation operates and franchises McDonald's restaurants in the United States and internationally. Its restaurants offer hamburgers and cheeseburgers, chicken sandwiches and nuggets, wraps, fries, salads, oatmeal, shakes, desserts, sundaes, soft serve cones, bakery items, soft drinks, coffee, and beverages and other beverages, as well as breakfast menu, including biscuit and bagel sandwiches, breakfast burritos, hotcakes, and other sandwiches. As of December 31, 2021, the company operated 40,031 restaurants. McDonald's Corporation was founded in 1940 and is headquartered in Chicago, Illinois.

Full MCD Calculator →
📬

Get this BPMC vs MCD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BPMC vs SCHDBPMC vs JEPIBPMC vs OBPMC vs KOBPMC vs MAINBPMC vs YUMBPMC vs QSRBPMC vs SBUX

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.